Here are all the membership benefits, join now!Show notesThis week our headline topic is a "concussion sensor" being trialled by some teams at the Tour de France, and why it is a welcome innovation, but one that, for now, invites potentially dangerous false hope
Tesfaye, H
Format 1 Separate Vials Standard research-vendor retatrutide vials (5 mg or 10 mg) plus standard cagrilintide vials (5 mg)
GLP1 therapies may exert antiinflammatory effects by reducing proinflammatory cytokines, which could theoretically lessen inflammatory stress on neural circuits involved in mood
The FDA, too, has cautioned about the potential danger of the compounds, and leading obesity medicine groups starkly warn patients against their use
The accumulation percentages here are model-derived from published Phase 2 pharmacokinetic data, not values measured directly in participants, and individual plasma levels vary